China CAS:58-22-0 Manufacturer

To be a result of ours specialty and repair consciousness, our corporation has won a good popularity amid consumers everywhere in the environment for CAS:58-22-0, We warmly welcome prospects, organization associations and mates from everywhere in the earth to get in touch with us and request cooperation for mutual benefits.
CAS:58-22-0, With high quality, reasonable price, on-time delivery and customized & customized services to help customers achieve their goals successfully, our company has got praise in both domestic and foreign markets. Buyers are welcome to contact us.

Hot Products

  • Mirabegron

    Mirabegron

    Mirabegron has In-house specification. DMF approved..

    CAS:223673-61-8

  • Lasmiditan Succinate

    Lasmiditan Succinate

    Lasmiditan Succinate has In-house specification. DMF approved.

    CAS:439239-92-6

  • Luliconazole

    Luliconazole

    Luliconazole has In-house specification, DMF approved.

    CAS:187164-19-8

  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

  • N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide

    N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide

    N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide is an intermediate of Dutasteride.

    CAS:98319-24-5

  • Flumethasone

    Flumethasone

    Flumethasone is a glucocorticoid, an anti-inflammatory. It can promptly decrease inflammation, exudation and itching is experienced after application.

    CAS:2135-17-3

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept